These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8063740)

  • 41. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor.
    Dudani AK; Pluskota A; Ganz PR
    Biochem Cell Biol; 1994; 72(3-4):126-31. PubMed ID: 7818846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
    Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
    Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation.
    Semov A; Moreno MJ; Onichtchenko A; Abulrob A; Ball M; Ekiel I; Pietrzynski G; Stanimirovic D; Alakhov V
    J Biol Chem; 2005 May; 280(21):20833-41. PubMed ID: 15788416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
    Siao CJ; Tsirka SE
    J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
    Fischer BE
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
    Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
    J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
    Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
    Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells.
    Fukao H; Matsuo O
    Semin Thromb Hemost; 1998; 24(3):269-73. PubMed ID: 9701459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells.
    Grimsley PG; Normyle JF; Brandt RA; Joulianos G; Chesterman CN; Hogg PJ; Owensby DA
    Thromb Res; 1995 Aug; 79(4):353-61. PubMed ID: 7482438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Competition between plasminogen and tissue plasminogen activator for cellular binding sites.
    Felez J; Chanquia CJ; Fabregas P; Plow EF; Miles LA
    Blood; 1993 Oct; 82(8):2433-41. PubMed ID: 8400293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
    Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
    Bu G; Morton PA; Schwartz AL
    J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
    Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
    Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Life Sci; 2000; 66(25):2473-87. PubMed ID: 10894090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.